awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26799896-F7A7922A-B893-442F-8B3F-2C85177C7743
Q26799896-F7A7922A-B893-442F-8B3F-2C85177C7743
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26799896-F7A7922A-B893-442F-8B3F-2C85177C7743
The past, present and future of immunotherapy against tumor
P2860
Q26799896-F7A7922A-B893-442F-8B3F-2C85177C7743
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26799896-F7A7922A-B893-442F-8B3F-2C85177C7743
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d45357dcbeec702350b2dd5711953c9cec88185
P2860
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.